West Pharmaceutical Services Inc (NYSE:WST) — Market Cap & Net Worth
Market Cap & Net Worth: West Pharmaceutical Services Inc (WST)
West Pharmaceutical Services Inc (NYSE:WST) has a market capitalization of $23.64 Billion ($23.64 Billion) as of September 20, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #1128 globally and #464 in its home market, demonstrating a 5.25% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying West Pharmaceutical Services Inc's stock price $362.31 by its total outstanding shares 70647595 (70.65 Million). Also see WST total asset value for a full breakdown of the balance sheet.
West Pharmaceutical Services Inc Market Cap History: 2015 to 2026
West Pharmaceutical Services Inc's market capitalization history from 2015 to 2026. Data shows growth from $4.10 Billion to $25.60 Billion (19.06% CAGR). Also see cash efficiency ratio of West Pharmaceutical Services Inc for how efficiently the company converts equity into cash flow.
Index Memberships
West Pharmaceutical Services Inc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P 500 Index
GSPC
|
$63.07 Trillion | 0.03% | #332 of 503 |
Weight: West Pharmaceutical Services Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
West Pharmaceutical Services Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how West Pharmaceutical Services Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check today's stock price for West Pharmaceutical Services Inc for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
6.32x
West Pharmaceutical Services Inc's market cap is 6.32 times its annual revenue
Latest Price to Earnings (P/E) Ratio
39.37x
West Pharmaceutical Services Inc's market cap is 39.37 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $5.82 Billion | $1.51 Billion | $143.60 Million | 3.86x | 40.54x |
| 2017 | $6.81 Billion | $1.60 Billion | $150.70 Million | 4.26x | 45.20x |
| 2018 | $6.81 Billion | $1.72 Billion | $206.90 Million | 3.96x | 32.90x |
| 2019 | $10.49 Billion | $1.84 Billion | $241.70 Million | 5.69x | 43.41x |
| 2020 | $19.83 Billion | $2.15 Billion | $346.20 Million | 9.24x | 57.29x |
| 2021 | $32.90 Billion | $2.83 Billion | $661.80 Million | 11.62x | 49.71x |
| 2022 | $16.55 Billion | $2.89 Billion | $585.90 Million | 5.74x | 28.24x |
| 2023 | $24.82 Billion | $2.95 Billion | $593.40 Million | 8.41x | 41.82x |
| 2024 | $23.14 Billion | $2.89 Billion | $492.70 Million | 8.00x | 46.97x |
| 2025 | $19.44 Billion | $3.07 Billion | $493.70 Million | 6.32x | 39.37x |
Competitor Companies of WST by Market Capitalization
Companies near West Pharmaceutical Services Inc in the global market cap rankings as of September 20, 2026. Review WST intangible-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to West Pharmaceutical Services Inc by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #179 globally with a market cap of $132.26 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #366 globally with a market cap of $75.25 Billion USD ( €64.36 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #422 globally with a market cap of $67.43 Billion USD ( €57.68 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #546 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #179 | Intuitive Surgical Inc | NASDAQ:ISRG | $132.26 Billion | $393.33 |
| #366 | EssilorLuxottica S. A. | PA:EL | $75.25 Billion | €139.00 |
| #422 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $67.43 Billion | €68.50 |
| #546 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
West Pharmaceutical Services Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, West Pharmaceutical Services Inc's market cap moved from $4.10 Billion to $ 25.60 Billion, with a yearly change of 19.06%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $25.60 Billion | +31.68% |
| 2025 | $19.44 Billion | -16.00% |
| 2024 | $23.14 Billion | -6.75% |
| 2023 | $24.82 Billion | +49.97% |
| 2022 | $16.55 Billion | -49.70% |
| 2021 | $32.90 Billion | +65.88% |
| 2020 | $19.83 Billion | +89.05% |
| 2019 | $10.49 Billion | +54.13% |
| 2018 | $6.81 Billion | -0.08% |
| 2017 | $6.81 Billion | +17.02% |
| 2016 | $5.82 Billion | +41.87% |
| 2015 | $4.10 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 20th, 2026 the market cap of West Pharmaceutical Services Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $23.64 Billion USD |
| MoneyControl | $23.64 Billion USD |
| MarketWatch | $23.64 Billion USD |
| marketcap.company | $23.64 Billion USD |
| Reuters | $23.64 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About West Pharmaceutical Services Inc
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; sy… Read more